Filing Flows › Cardiff Oncology (CRDF) › Q2 2026 › vs Q1 2026
Cardiff Oncology (CRDF) Q2 2026 vs Q1 2026 (quarter over quarter)
Cardiff Oncology's revenue rose $63K (+154%) from $41K in Q1 2026 to $104K in Q2 2026.
Cardiff Oncology, Q2 2026: revenue $104K (-14% year over year), net loss $9.2M, operating cash flow −$11.8M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $104K | $41K | $63K | +154% |
| Other income, net | $383K | $505K | −$122K | -24% |
| Net loss | $9.2M | $12.3M | −$3.1M | -25% |
| Costs & expenses | $9.7M | $12.9M | −$3.2M | -25% |
| Operating costs | $9.7M | $12.9M | −$3.2M | -25% |
| Research & development | $5.9M | $6.8M | −$850K | -13% |
| SG&A | $3.8M | $6.1M | −$2.3M | -38% |
| Operating cash sources | $12.8M | $14.0M | −$1.3M | -9% |
| Depreciation | $87K | $87K | $0 | 0% |
| Share-based compensation | $920K | $1.7M | −$740K | -45% |
| Cash used in operations | $11.8M | $12.3M | −$523K | -4% |
| Net loss absorbed | $9.2M | $12.3M | −$3.1M | -25% |
| Working capital & other | $3.5M | $1.7M | $1.9M | +109% |
Questions
How much did Cardiff Oncology's revenue grow quarter over quarter in Q2 2026?
Cardiff Oncology's revenue rose $63K (+154%) from $41K in Q1 2026 to $104K in Q2 2026.